Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 26;11(11):1137.
doi: 10.3390/life11111137.

Animal Models of LED-Induced Phototoxicity. Short- and Long-Term In Vivo and Ex Vivo Retinal Alterations

Affiliations
Review

Animal Models of LED-Induced Phototoxicity. Short- and Long-Term In Vivo and Ex Vivo Retinal Alterations

Juan A Miralles de Imperial-Ollero et al. Life (Basel). .

Abstract

Phototoxicity animal models have been largely studied due to their degenerative communalities with human pathologies, e.g., age-related macular degeneration (AMD). Studies have documented not only the effects of white light exposure, but also other wavelengths using LEDs, such as blue or green light. Recently, a blue LED-induced phototoxicity (LIP) model has been developed that causes focal damage in the outer layers of the superior-temporal region of the retina in rodents. In vivo studies described a progressive reduction in retinal thickness that affected the most extensively the photoreceptor layer. Functionally, a transient reduction in a- and b-wave amplitude of the ERG response was observed. Ex vivo studies showed a progressive reduction of cones and an involvement of retinal pigment epithelium cells in the area of the lesion and, in parallel, an activation of microglial cells that perfectly circumscribe the damage in the outer retinal layer. The use of neuroprotective strategies such as intravitreal administration of trophic factors, e.g., basic fibroblast growth factor (bFGF), brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF) or pigment epithelium-derived factor (PEDF) and topical administration of the selective alpha-2 agonist (Brimonidine) have demonstrated to increase the survival of the cone population after LIP.

Keywords: LED induced phototoxicity; cone photoreceptor; microglia activation; neuroprotection; retinal pigment epithelium.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Iba-1+ cells in outer segment layer (OSL) after LIP. Wholemount retina of a retina photo-exposed 3 days after LIP with an Iba-1+ reaction in the OSL after LIP (green) in the centre of the lesion in an albino rat retina (A). Confocal magnification of a right eye retina (RE) without microglial cells in OSL (red; B) and of a damage retina at 3 days after LIP where Iba-1+ cells (green) were observed in the center of the lesion and localised in OSL (red; C). Magnifications of Iba-1+ cells located in OSL at 1, 3, 7, 14 and 30 days after LIP in which morphological changes were observed from a dendritic shape at 1 day to an ameboid shape at 3 days after LIP and progressively returning to an elongated morphology (DH). Bar scale in A = 1 mm; in D-H = 50 µm.
Figure 2
Figure 2
RPE analysis ex vivo by labelling zonulas occludens (AD,G,H) and in vivo by blue autofluorescence (BAF; F,I). In the right eyes (RE) RPE showed a hexagonal and regular morphology (A,B). Intravitreal bFGF-treated retinas (C) showed less pleomorphism at 3 days after LIP than vehicle retinas (treated intravitreally with saline; D). However, these differences disappeared 7 days after LIP with similar RPE morphology in the bFGF group and vehicles (G,H). In addition, RPE alterations were observed by BAF one day after LIP with a hypo-autofluorescent circle in the lesion area leading to a hyper-autofluorescent spot in the circular lesion area at 7 days (F,I). Bar scale in (A) = 250 µm; in (BD,G,H) = 100 µ; in (F,I) = 600 µm.

Similar articles

Cited by

References

    1. Friedman D.S., O’Colmain B.J., Munoz B., Tomany S.C., McCarty C., de Jong P.T., Nemesure B., Mitchell P., Kempen J., Eye Diseases Prevalence Research G. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004;122:564–572. - PubMed
    1. Klein R., Cruickshanks K.J., Nash S.D., Krantz E.M., Nieto F.J., Huang G.H., Pankow J.S., Klein B.E. The prevalence of age-related macular degeneration and associated risk factors. Arch. Ophthalmol. 2010;128:750–758. doi: 10.1001/archophthalmol.2010.92. - DOI - PMC - PubMed
    1. Bourne R.R., Stevens G.A., White R.A., Smith J.L., Flaxman S.R., Price H., Jonas J.B., Keeffe J., Leasher J., Naidoo K., et al. Causes of vision loss worldwide, 1990–2010: A systematic analysis. Lancet Glob. Health. 2013;1:e339–e349. doi: 10.1016/S2214-109X(13)70113-X. - DOI - PubMed
    1. Wong W.L., Su X., Li X., Cheung C.M., Klein R., Cheng C.Y., Wong T.Y. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis. Lancet Glob. Health. 2014;2:e106–e116. doi: 10.1016/S2214-109X(13)70145-1. - DOI - PubMed
    1. Nowak J.Z. AMD—The retinal disease with an unprecised etiopathogenesis: In search of effective therapeutics. Acta Pol. Pharm. 2014;71:900–916. - PubMed

LinkOut - more resources